Evidence map›Paper›PMID 36175413›Full record

ArticleNature communications2022

Adversarial attacks and adversarial robustness in computational pathology.

Narmin Ghaffari Laleh, Daniel Truhn, Gregory Patrick Veldhuizen, Tianyu Han, Marko van Treeck, Roman D Buelow, Rupert Langer, Bastian Dislich, Peter Boor, Volkmar Schulz and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 104 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Decoding pathology: the role of computational pathology in research and diagnostics.Pflugers Archiv : European journal of physiology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. [Artificial intelligence in kidney transplant pathology].Pathologie (Heidelberg, Germany) · 2024
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Narmin Ghaffari LalehDepartment of Medicine III, University Hospital RWTH Aachen, RWTH Aachen university, Aachen, Germany.
Daniel TruhnDepartment of Diagnostic and Interventional Radiology, University Hospital Aachen, Aachen, Germany.
Gregory Patrick VeldhuizenElse Kroener Fresenius Center for Digital Health, Medical Faculty Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
Tianyu HanDepartment of Physics of Molecular Imaging Systems, Institute for Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany.ORCID 0000-0002-8636-6462
Marko van TreeckDepartment of Medicine III, University Hospital RWTH Aachen, RWTH Aachen university, Aachen, Germany.
Roman D BuelowInstitute of Pathology, University Hospital RWTH Aachen, Aachen, Germany.ORCID 0000-0002-8527-7353
Rupert LangerInstitute of Pathology, University of Bern, Bern, Switzerland.
Bastian DislichInstitute of Pathology, University of Bern, Bern, Switzerland.
Peter BoorInstitute of Pathology, University Hospital RWTH Aachen, Aachen, Germany.ORCID 0000-0001-9921-4284
Volkmar SchulzDepartment of Physics of Molecular Imaging Systems, Institute for Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany.ORCID 0000-0003-1341-9356
Jakob Nikolas KatherDepartment of Medicine III, University Hospital RWTH Aachen, RWTH Aachen university, Aachen, Germany. jakob_nikolas.kather@tu-dresden.de.ORCID 0000-0002-3730-5348
RWTH Aachen University · DEUniversity of Bern · CHFraunhofer Institute for Digital Medicine · DEUniversitätsklinikum Aachen · DEUniversity Hospital Carl Gustav Carus · DEUniversity of Leeds · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial Intelligence (AI) can support diagnostic workflows in oncology by aiding diagnosis and providing biomarkers directly from routine pathology slides. However, AI applications are vulnerable to adversarial attacks. Hence, it is essential to quantify and mitigate this risk before widespread clinical use. Here, we show that convolutional neural networks (CNNs) are highly susceptible to white- and black-box adversarial attacks in clinically relevant weakly-supervised classification tasks. Adversarially robust training and dual batch normalization (DBN) are possible mitigation strategies but require precise knowledge of the type of attack used in the inference. We demonstrate that vision transformers (ViTs) perform equally well compared to CNNs at baseline, but are orders of magnitude more robust to white- and black-box attacks. At a mechanistic level, we show that this is associated with a more robust latent representation of clinically relevant categories in ViTs compared to CNNs. Our results are in line with previous theoretical studies and provide empirical evidence that ViTs are robust learners in computational pathology. This implies that large-scale rollout of AI models in computational pathology should rely on ViTs rather than CNN-based classifiers to provide inherent protection against perturbation of the input data, especially adversarial attacks.

Indexed as

Artificial IntelligenceNeural Networks, ComputerElectric Power SuppliesKnowledgeWorkflow

Identifiers

PMID36175413
PMCPMC9522657
OpenAlexW4298001211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.